The most common type of hereditary angioedema (HAE) is the result of impaired C1 inhibitor (C1-INH) activity (HAE-C1-INH) due to protein deficiency (type I) or dysfunction (type II) and was identified in 1963 by Virginia Donaldson [3]. This evidence concerns the gene SERPING1 and protein S deficiency.